Newbridge Financial Services Group’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$158 Hold
8
﹤0.01% 1188
2026
Q1
$154 Sell
8
-8
-50% -$158 ﹤0.01% 1138
2025
Q4
$299 Hold
16
﹤0.01% 1124
2025
Q3
$290 Buy
16
+1
+7% +$19 ﹤0.01% 1238
2025
Q2
$282 Hold
15
﹤0.01% 1256
2025
Q1
$263 Hold
15
﹤0.01% 989
2024
Q4
$256 Sell
15
-700
-98% -$12.8K ﹤0.01% 1082
2024
Q3
$13.3K Sell
715
-2,446
-77% -$41.2K ﹤0.01% 402
2024
Q2
$48.7K Sell
3,161
-4,246
-57% -$60.7K 0.02% 380
2024
Q1
$109K Buy
7,407
+3,507
+90% +$48.6K 0.05% 274
2023
Q4
$55.7K Buy
+3,900
New +$55.4K 0.03% 367
2023
Q2
Sell
-2,308
Closed -$26.5K 1433
2023
Q1
$26.5K Buy
2,308
+908
+65% +$11.2K 0.01% 627
2022
Q4
$17.4K Buy
+1,400
New +$17.9K 0.01% 768

Other funds holding SBRA

Newbridge Financial Services Group's SBRA Position: Q2 2026 in Review

Newbridge Financial Services Group held its Sabra Healthcare REIT (SBRA) position steady in Q2 2026 at 8 shares worth $158. The position accounts for ﹤0.01% of the portfolio, ranked #1188.

Newbridge Financial Services Group first reported a position in SBRA in Q4 2022 and has held it in 13 quarters since. The position peaked at $109K in Q1 2024. 464 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.

  • Newbridge Financial Services Group held 8 shares of Sabra Healthcare REIT worth $158 as of Q2 2026.
  • Newbridge Financial Services Group left its Sabra Healthcare REIT share count unchanged in Q2 2026.
  • Sabra Healthcare REIT made up ﹤0.01% of Newbridge Financial Services Group's portfolio in Q2 2026, its #1188 holding.
  • Newbridge Financial Services Group first reported a position in Sabra Healthcare REIT in Q4 2022 and has held it in 13 quarters since.
  • Newbridge Financial Services Group's Sabra Healthcare REIT position peaked at $109K in Q1 2024.
  • 464 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.

Based on Newbridge Financial Services Group's 13F filing for Q2 2026, filed 14 Aug 2026.